COVID-19 Clinical Trials

Find COVID-19 Clinical Trials Near You

COVID-19 Vaccines Safety Tracking: Global Consortium Study

Status: Recruiting
Location: See all (13) locations...
Intervention Type: Biological
Study Type: Observational
SUMMARY

This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• HCW, OA and ST who received COVID-19 vaccine.

• Participating subjects should be at least 18-year-old and able to give their informed consent independently.

Locations
United States
Pennsylvania
American College of Physicians
NOT_YET_RECRUITING
Philadelphia
Other Locations
Canada
McMaster University
NOT_YET_RECRUITING
Hamilton
Croatia
University of Split
NOT_YET_RECRUITING
Split
Estonia
University of Tartu
NOT_YET_RECRUITING
Tartu
Ethiopia
Jimma University
RECRUITING
Jimma
Germany
Justus-Liebig University Giessen
RECRUITING
Giessen
Ghana
University of Ghana
NOT_YET_RECRUITING
Accra
Mexico
Sinaloa's Pediatric Hospital
NOT_YET_RECRUITING
Culiacán
Poland
Medical University of Silesia
RECRUITING
Katowice
Portugal
Nursing School of Coimbra
NOT_YET_RECRUITING
Coimbra
Russian Federation
Irkutsk Scientific Center of Siberian Branch of Russian Academy of Sciences
RECRUITING
Irkutsk
Serbia
University of Belgrade
RECRUITING
Belgrade
Slovenia
University of Ljubljana
NOT_YET_RECRUITING
Ljubljana
Contact Information
Primary
Miloslav Klugar, PhD
klugar@med.muni.cz
+420549495676
Backup
Abanoub Riad, DDS
abanoub.riad@med.muni.cz
+420549496572
Time Frame
Start Date: 2021-04-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 30000
Treatments
Pfizer-BioNTech COVID-19 Vaccine
Recently vaccinated individuals by Pfizer-BioNTech COVID-19 Vaccine (Comirnaty)
Moderna COVID-19 Vaccine
Recently vaccinated individuals by Moderna COVID-19 Vaccine
AstraZeneca-Oxford University COVID-19 Vaccine
Recently vaccinated individuals by AstraZeneca-Oxford University COVID-19 Vaccine (Vaxzevria)
CoronaVac
Recently vaccinated individuals by CoronaVac (Sinovac COVID-19 Vaccine)
Sinopharm
Recently vaccinated individuals by Vero Cells (Sinopharm COVID-19 Vaccine)
Sputnik V
Recently vaccinated individuals by Sputnik V COVID-19 Vaccine
Janssen
Recently vaccinated individuals by Janssen COVID-19 Vaccine
CureVac
Recently vaccinated individuals by CureVac COVID-19 Vaccine
Novavax
Recently vaccinated individuals by Novavax COVID-19 Vaccine
Covaxin
Recently vaccinated individuals by Covaxin COVID-19 Vaccine
CanSino
Recently vaccinated individuals by CanSino COVID-19 Vaccine
Related Therapeutic Areas
Sponsors
Leads: Masaryk University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials